Metabolic syndrome in African Americans: implications for preventing coronary heart disease

Luther T Clark1, Fadi El-Atat

  • 1Professor of Clinical Medicine, Chief, Division of Cardiovascular Medicine, State University of New York Downstate Medical Center, Brooklyn, New York 11203, USA. ltclark@downstate.edu

Clinical Cardiology
|April 20, 2007
PubMed

Insights

Metabolic syndrome, a cluster of risk factors, affects 1 in 4 American adults, increasing diabetes and cardiovascular disease risk. Management focuses on lifestyle changes and controlling key factors like blood pressure and dyslipidemia.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Metabolic syndrome is a cluster of cardiovascular risk factors including obesity, high blood pressure, and insulin resistance.
  • It affects approximately 50 million American adults, significantly increasing their risk for diabetes and cardiovascular disease.
  • African Americans, particularly women, exhibit a high prevalence due to factors like elevated blood pressure, obesity, and diabetes.

Purpose of the Study:

  • To summarize the definition and prevalence of metabolic syndrome.
  • To highlight the increased risks associated with metabolic syndrome.
  • To outline the primary management strategies and their potential impact on cardiovascular risk.

Main Methods:

  • Review of existing literature on metabolic syndrome definition, prevalence, and risk factors.
  • Analysis of contributing factors to high prevalence in specific populations.
  • Synthesis of current management approaches and their efficacy.

Main Results:

  • Metabolic syndrome affects about 25% of American adults, elevating risks for diabetes and cardiovascular disease.
  • Elevated blood pressure, obesity, and diabetes disproportionately affect African Americans, contributing to higher metabolic syndrome prevalence.
  • Addressing overweight/obesity and physical inactivity are primary management goals.
  • Optimal control of atherogenic dyslipidemia and elevated blood pressure can reduce cardiovascular risk by over 80%.

Conclusions:

  • Metabolic syndrome is a significant public health concern due to its high prevalence and associated risks.
  • Lifestyle modifications and targeted risk factor management are crucial for controlling metabolic syndrome.
  • Effective management of key components like blood pressure and dyslipidemia offers substantial cardiovascular risk reduction.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...